Area 3 of 3
Deep technology, first market
The science works. Now someone has to buy it. We work at that point: the first buyer, the price, the partner and the country.
By Alessandro Singh and Rohith Varma, Last reviewed , 8-minute read
What we mean
We mean quantum, new computing, materials and biology at the point they become a product someone buys.
By deep technology, we mean companies built on a scientific or engineering advance, with technical work still to finish. Most people shorten it to deep tech, and call the step we work on commercialisation. The commercial questions depend on the company's stage: who has the problem, who can buy, what evidence they need and what the next milestone costs.
Here the second deployment is decided at the first: the first buyer, the first unit and the first country are chosen so that a second can follow.
Scientific assessment is work for qualified specialists. Ours is the commercial side.
This page is for you if the science works and one customer has bought, and the next buyer is not in sight or the first was a laboratory.
What we look for
Our thesis is that a technology company is proven at the second deployment. These are its five tests, as they apply here.
- Proof in use. The system runs outside the lab, in a customer's setting, and the customer keeps using it.
- A buyer who pays. A first buyer with a budget and a reason to go first: a national laboratory, a public body, a utility or a demanding niche customer. That sale is a start, not the test. The test is a buyer who runs it in its own operations and pays from an operating budget. The first product is often small. One battery-materials company launched its material in a fitness wearable.Source 1
- A way to deploy again. In deep technology the second deployment is the second unit, made and sold to a second buyer at a price that can fall: the first unit is expensive, and the plan shows why the next ones cost less. In 2023 the US Department of Energy said repeat deployments of advanced nuclear reactors are expected to help cut their overnight capital costs by 40%.Source 2
- A way to support it. A partner who already owns what the company lacks: the plant, the channel or the service network.
- A route through the rules. Approvals, standards and export controls are mapped country by country, and the first country is chosen on purpose. In 2025 a Japanese food group launched products in Singapore that contain a Finnish company's protein, made from carbon dioxide and electricity. The protein had approval in Singapore in September 2022. In the EU, where the company applied in October 2021, the food safety authority gave a positive opinion in November 2026, and the company expects final authorisation to take another seven to nine months.Source 3
Source 4
Why now
Public bodies have started to buy first. In February 2024 UK Research and Innovation and the National Quantum Computing Centre announced £30 million of contracts with seven companies to deliver quantum computing testbeds at the centre. All seven were delivered by the end of 2025, and the centre calls its role that of a first customer (National Quantum Computing Centre, 2026). A buyer like that pays to learn what the technology can do.Source 5
Products are on sale. One European maker of quantum computers reports 31 systems sold and 17 delivered, with orders of €102 million still to deliver at the end of September 2026. Its revenue was €8.9 million in the third quarter, and it booked a €33 million contract with a public supercomputing centre. A British company sells a graphene device, made in its own foundry, from its online store.Source 7
Early money is there, and later money comes from abroad. Deep technology, counted widely to include AI and defence, took 32% of European venture capital in 2025, against 15% in 2015. In the UK, the Royal Academy of Engineering's 2026 report found that domestic investors provide 59% of early-stage funding for deep technology and 21% of later-stage funding. It also names complex procurement and the difficulty of winning early customers among the frictions that slow companies down. A company with paying customers has more say in who funds it next.Source 9
The evidence
What the funding data and the research found. Each line is one finding.
- Capital thins out as companies grow. In Europe, 54% of the money in deep technology funding rounds above $15 million comes from within Europe, against 80% in the US (Dealroom and partners, 2026).Source 9
- Later money comes from the US. US investors provide 55% of late-stage funding for UK deep technology (Royal Academy of Engineering, 2026).Source 10
- Fewer reach scale. Of UK deep technology startups, 2.8% reach a billion-dollar valuation or exit (a sale or a listing), or $100 million of revenue, against 6.5% in the US (Royal Academy of Engineering, 2026).Source 11
- Public money can be the first proof. An early grant from the US Department of Energy's small business programme roughly doubled a firm's chance of later venture capital, and had large positive effects on its patenting and revenue. The grant paid for a prototype (Howell, American Economic Review, 2017).Source 12
- Europe has a public first backer. The European Innovation Council's fund has invested more than €1.7 billion in nearly 350 companies, with about €5 billion from other investors beside it, and its work with large companies has led to 51 signed deals since 2024 (European Innovation Council, 2026).Source 13
- First prices are learning prices. In 2022 Frontier, a buyers' group for carbon removal, agreed prices of $500 to $1,800 a tonne with six suppliers on behalf of one member, and said it was the first customer of each. That member committed $2.4 million and made a further $5.4 million depend on technical milestones (Frontier, 2022).Source 14
- The first market can be misjudged. One US biomanufacturing company told shareholders in its 2021 annual report that its first product had a smaller near-term market than it had expected, and stopped making it (company filing, 2022).Source 15
Taken together: the first money and the first buyer are often public, and the first price is a learning price. The step no grant pays for is the first buyer who runs the product in its own operations.
Where this could be wrong
Selling the technology can be the right outcome. More than 80% of European deep technology exits come through mergers and acquisitions, as counted in the 2026 European Deep Tech Report, and buyers from the US accounted for most of the value of those acquisitions. So where a sale is the better route, we say so before anyone builds a sales team.Source 9
A first customer can prove the wrong thing. A laboratory or a government programme shows the science works; it does not show that a business will pay to run it. A 2022 evaluation of the UK's Small Business Research Initiative found that the firms it funded grew their staff 9.4% more than comparable firms from 2019 to 2020. It found no statistically significant effect on their turnover, which the evaluators call not unusual, given time lags and small numbers. The buyer of the quantum testbeds says it is too early to assess their full impact. So we look for a buyer who runs it in its own operations.Source 17
Sometimes the factory is the test. Venture capital firms put more than $25 billion into clean energy startups from 2006 to 2011 and lost over half of it. Returns were dragged down by companies developing new materials, chemistries or processes that never reached manufacturing scale (Gaddy and others, Energy Policy, 2017). Scaling up an industrial microbial process often takes more time and money than developing the microbe and the process in the laboratory (Crater and Lievense, FEMS Microbiology Letters, 2018). A Swedish battery maker filed for bankruptcy in March 2025, naming among its reasons the difficulty of ramping up production. So we ask who will make the product at volume before we ask who will buy it.Source 18
It can take longer than a fund lasts. Commercial work does not shorten the science or the approval. So we start when there is a product a customer can use, and we say so when there is not.
What would change our mind: if by our review in May 2027 the first sales in a field have all gone to laboratories and none to a buyer who runs the product in its own operations, we are too early in that field, and we will say so here.
Last reviewed We review this page every six months. When we change our view, the old view stays here, with the date and the reason.
What we bring
For deep technology companies, we do the commercial work, in three parts. The buyers: we help choose the first buyer and shape an offer it can approve. The route in: the first country, its approvals and its partners. The people who run it: senior leaders, part-time until your permanent team is in place.
From the founders' careersStrategic investors brought in from seed to Series C, some of whom went on to become customers.
When it is time to raise, we help you raise: the story, the numbers, the data room, an investor strategy and support through the round. Introductions and transaction mandates are arranged through regulated partners.
For funds and corporate venture teams, we scout and screen companies in this area against your thesis, and write up where each stands on the five tests. The note is factual and commercial, with no recommendation to invest or pass.
We also invest our own money when the fit is right, and can take part of a fee in equity. Size and terms are agreed case by case, in writing. Every stake is disclosed in writing to every client involved.
If we have an interest, we say so. If it conflicts, we step back.
The science works and one customer has bought? Tell us who you think buys next.
Newsletter
One email a month
Our newest notes, and what we are seeing in AI, machines at work and deep technology.
Sources
In the order we cite them, with the day we read each one.
1. About Sila: the home of silicon battery technology (opens in a new tab)
Sila (the company's own page), Accessed , Back to the text, where source 1 is cited
2. Commercializing Advanced Nuclear Reactors Explained in Five Charts (opens in a new tab)
US Department of Energy, Office of Nuclear Energy, , Accessed , Back to the text, where source 2 is cited
Solar Foods (the company's own release, published by Inderes), , Accessed , Back to the text, where source 3 is cited
Solar Foods (the company's own release, published by Inderes), , Accessed , Back to the text, where source 4 is cited
5. UKRI and NQCC invest £30 million in UK quantum innovators (opens in a new tab)
UK Research and Innovation, , Accessed , Back to the text, where source 5 is cited
6. Quantum Computing Testbed Initiative (QCTI): Phase 1 Report (opens in a new tab)
National Quantum Computing Centre, with Innovate UK (the buyer's own report), , Accessed , Back to the text: citation 1 of source 6, a citation 2 of source 6, b
IQM Quantum Computers (the company's own release, as filed with the US Securities and Exchange Commission), , Accessed , Back to the text, where source 7 is cited
8. Paragraf Introduces PMF2000 GFET (opens in a new tab)
Paragraf (the company's own release), , Accessed , Back to the text, where source 8 is cited
9. The European Deep Tech Report 2026 (opens in a new tab)
Dealroom, with Lakestar, Walden Catalyst and Hello Tomorrow (a report by a data provider and investors; the exit figures are in its executive summary, page 3 of the full report), , Accessed , Back to the text: citation 1 of source 9, a citation 2 of source 9, b citation 3 of source 9, c
10. Record year for UK deep tech with 13 unicorns and over 70% of investment in AI (opens in a new tab)
Royal Academy of Engineering (its release on the same report), , Accessed , Back to the text: citation 1 of source 10, a citation 2 of source 10, b
11. State of UK Deep Tech 2026 (opens in a new tab)
Royal Academy of Engineering, with data from Dealroom, , Accessed , Back to the text, where source 11 is cited
12. Financing Innovation: Evidence from R&D Grants (opens in a new tab)
Sabrina T. Howell, American Economic Review 107(4), , Accessed , Back to the text, where source 12 is cited
13. EIC Impact Report 2026: Created and scaled in Europe (opens in a new tab)
European Innovation Council, European Commission (the Council's own report), , Accessed , Back to the text, where source 13 is cited
14. Frontier facilitates first carbon removal purchases (opens in a new tab)
Frontier (the buyers' own announcement), , Accessed , Back to the text, where source 14 is cited
15. Zymergen Inc., Annual Report on Form 10-K for the year 2021 (opens in a new tab)
Zymergen (the company's own annual report, as filed with the US Securities and Exchange Commission), , Accessed , Back to the text, where source 15 is cited
16. The 2026 European Deeptech Report: Sector reaches $690B as VC share hits record (opens in a new tab)
tech.eu (press report of the same report), , Accessed , Back to the text, where source 16 is cited
17. An Evaluation of the Small Business Research Initiative (SBRI): final report (opens in a new tab)
Steer Economic Development, for UK Research and Innovation, , Accessed , Back to the text, where source 17 is cited
18. Venture Capital and Cleantech: The wrong model for energy innovation (opens in a new tab)
Benjamin E. Gaddy, Varun Sivaram, Timothy B. Jones and Libby Wayman, Energy Policy 102 (first an MIT Energy Initiative working paper, 2016), , Accessed , Back to the text, where source 18 is cited
19. Scale-up of industrial microbial processes (opens in a new tab)
Jason S. Crater and Jefferson C. Lievense, FEMS Microbiology Letters 365(13), , Accessed , Back to the text, where source 19 is cited
20. Northvolt files for bankruptcy in Sweden (opens in a new tab)
Northvolt (the company's own statement), , Accessed , Back to the text, where source 20 is cited